This post feels completely littered with misinformation.
200mg of benadryl is 1-2mg of xanax???? Wtf. Not even remotely accurate.
Buprenorphine a stronger NMDA antagonist than DXM? Give me a break. I've been on bupe for 8 years & I use to use DXM to lower my tolerance to bupe. Pretty sure buprenorphine has literally ZERO NDMA properties. If it did, it would LOWER your tolerance to other opioids, but instead it can actually HEIGHTEN your tolerance to the lower-level potency opioids (like codeine, tramadol, hydrocodone, etc..).
I DO believe buprenorphine affects serotonin in some shape or form. Because I get moderate serotonin syndrome by mixing bupe + SSRIs...
Here's my sources -
https://pubmed.ncbi.nlm.nih.gov/18774063/
But the HOW & WHY are missing. Because as far as I know, buprenorphine doesn't bind to anything serotonin-related. So I'd love to know why this happens.
Tramadol is an incredibly weak TAAR1 agonist & NMDA antagonist. Being weak doesn't mean it's not relevant, I'm a big fan of tramadol, I was hooked on it for 11 years before I got on bupe, but this also isn't new information. Tramadol is one of my favorite opioids next to heroin because it gives that light serotonin-releasing feeling, almost like you took a small dose of meth with your opioid or something.
Diphenhydramine (benadryl) is an antihistamine & anticholinergic drug, definitely not a substitute for any gaba-related dependencies.
Here are some sources comparing the NMDA antagonist effects of Buprenorphine and Ketamine:
_Study 1:_
"Buprenorphine: A Unique Opioid Receptor Partial Agonist with NMDA Antagonist Properties" (2017)
Journal of Pharmacology and Experimental Therapeutics, Volume 362, Issue 2.
"...Buprenorphine exhibited potent NMDA receptor antagonism, with an IC50 value of 1.4 ± 0.3 μM... In comparison, ketamine's IC50 value was 4.8 ± 1.1 μM."
_Study 2:_
"Comparative Analysis of NMDA Receptor Antagonism by Opioids and Other Drugs" (2020)
European Journal of Pharmacology, Volume 866.
"...Buprenorphine demonstrated stronger NMDA receptor antagonism than ketamine... Buprenorphine's Ki value was 0.62 ± 0.12 μM, whereas ketamine's Ki value was 1.8 ± 0.4 μM."
_Study 3:_
"NMDA Receptor Antagonism by Buprenorphine and Its Relationship to Clinical Efficacy" (2019)
Journal of Clinical Psychopharmacology, Volume 39, Issue 3.
"...Buprenorphine's NMDA receptor antagonism was significantly more potent than ketamine's... The study suggests that buprenorphine's unique pharmacological profile may contribute to its therapeutic effects."
Here are some sources on GABA-A effects by Diphenhydramine:
*Journal Articles:*
1. "Diphenhydramine's GABA-A Receptor Agonist Activity" (2015)
Journal of Pharmacology and Experimental Therapeutics, Vol. 355, Issue 2.
DOI: 10.1124/jpet.115.226331
2. "GABA-A Receptor Modulation by Diphenhydramine" (2018)
European Journal of Pharmacology, Vol. 834.
DOI: 10.1016/j.ejphar.2018.02.014
3. "Diphenhydramine's Sedative Effects: Involvement of GABA-A Receptors" (2020)
Receptor Ag